Genetically modified anti-third party central memory T cells and use of same in… Grant US-11844827-B2 United States of America 19 Dec 2023
Genetically modified veto cells and use of same in immunotherapy Grant US-11555178-B2 United States of America 17 Jan 2023
Anti third party central memory T cells, methods of producing same and use of same in… Grant US-11324777-B2 United States of America 10 May 2022
Genetically modified anti-third party central memory T cells and use of same in… Grant US-11179448-B2 United States of America 23 Nov 2021
Methods of transplantation and disease treatment Grant US-10933124-B2 United States of America 02 Mar 2021
Methods of transplantation and disease treatment Grant US-10751368-B2 United States of America 25 Aug 2020
High affinity T cell receptor and use thereof Grant US-10626159-B2 United States of America 21 Apr 2020
Use of human cells of myeloid leukemia origin for expression of antibodies Grant US-10280230-B2 United States of America 07 May 2019
METHODS FOR GENERATING ENGINEERED HUMAN PRIMARY BLOOD DENDRITIC CELL LINES Application EP-3364985-A4 European Patent Office 27 Mar 2019
High affinity T cell receptor and use thereof Grant US-9862755-B2 United States of America 09 Jan 2018
Plasmacytoid dendritic cell line used in active or adoptive cell therapy Grant US-9783782-B2 United States of America 10 Oct 2017
Anti third party central memory T cells, methods of producing same and use of same in… Grant US-9738872-B2 United States of America 22 Aug 2017
Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells Grant US-9597384-B2 United States of America 21 Mar 2017
Microorganisms or fractions thereof capable of activating cellular immunity against… Grant US-9494587-B2 United States of America 15 Nov 2016
Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment Application US-9421228-B2 United States of America 23 Aug 2016
Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells Grant US-9238063-B2 United States of America 19 Jan 2016
For initiatively or the plasmacytoid dendritic cells system of adoptive cell therapy Application CN-102165057-B China 29 Jul 2015
Use of human cells of myeloid leukaemia origin for expression of antibodies Grant US-9051356-B2 United States of America 09 Jun 2015
Therapeutic cancer vaccines derived from a novel dendritic cell line Application EP-2743344-A1 European Patent Office 18 Jun 2014
High affinity T cell receptor and use thereof Grant US-8697854-B2 United States of America 15 Apr 2014
Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof Grant US-8592165-B2 United States of America 26 Nov 2013
METHOD FOR IDENTIFYING AGENTS CAPABLE OF INDUCING RESPIRATORY SENSITIZATION AND ARRAY AND… Application WO-2013160882-A1 World Intellectual Property Organisation (WIPO) 31 Oct 2013
Production and use of human CD124 and CD116 positive tumour cell lines in the production… Application EP-2361973-A3 European Patent Office 15 Aug 2012